Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.
2
FOR
0
AGAINST
0
WITHHOLD
2
BALLOT ITEMS
ITEM-BY-ITEM RECOMMENDATIONS
1
To approve, in accordance with Nasdaq listing rules, the potential future issuance of shares of our common stock upon the exercise of outstanding warrants
other Routine
For
BoardFOR·Duopolyunknown—No divergence flagged
Approval is required for warrant exercises under Nasdaq listing rules and the purchase agreement.